CARLSBAD, Calif.--(BUSINESS WIRE)--Dec. 15, 2008--Life Technologies Corporation (NASDAQ:LIFE), announced today that the company will be included in the NASDAQ-100 Index, effective at market open on December 22, 2008.
Launched in January 1985, the NASDAQ-100 Index represents the largest non-financial domestic and international securities listed on the NASDAQ Stock Market based on market capitalization. The index includes leading companies from major industry groups such as computer hardware and software, telecommunications, retail/wholesale trade and biotechnology.
"Life Technologies is honored to be included in this year's NASDAQ-100 Index and to be in the company of other organizations symbolizing entrepreneurial success," said Greg Lucier, Chairman and Chief Executive Officer of Life Technologies. "Our inaugural listing reflects the scale we achieved in 2008 with the merger of Invitrogen and Applied Biosystems. We look forward to delivering upon the promise of our combination by helping scientists make breakthrough discoveries that will ultimately improve life."
With a market capitalization of approximately $3.8 billion, Life Technologies is a global biotechnology tools company that provides researchers with products and services to accelerate scientific discovery and improve the human condition. Its customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics.
About Life Technologies
Life Technologies (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company has historical sales of approximately $3.5 billion, employs 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of over 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference, please visit our website: www.lifetechnologies.com.
Safe Harbor Statement
Certain statements contained in this press release are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is Life Technologies' intent that such statements be protected by the safe harbor created thereby. Potential risks and uncertainties include, but are not limited to: potential difficulties that may be encountered in integrating the merged businesses; potential uncertainties regarding market acceptance of Life Technologies; Life Technologies' ability to protect its intellectual property rights; competitive responses to the merger; an economic downturn, including the deterioration in economic and market conditions currently being experienced; risks that revenues may be lower than expected; Life Technologies' ability to make accurate estimates and control costs; Life Technologies' and its partners' ability to bid on, win, perform and renew contracts and projects; the need to develop new products and adapt to significant technological change; exposure to environmental liabilities and litigation; liabilities for pending and future litigation; the impact of changes in laws and regulations; industry competition; Life Technologies' ability to attract and retain key employees; employee, agent or partner misconduct; risks associated with changes in equity-based compensation requirements; Life Technologies' leveraged position and ability to service debt; risks associated with international operations; third-party software risks; terrorist and natural disaster risks; anti-takeover risks and other factors; as well as other risks and uncertainties detailed from time to time in Life Technologies' Securities and Exchange Commission filings.
CONTACT: Life Technologies Corporation Investor Relations Amanda Clardy, 760-476-7075 Amanda.clardy@lifetech.com or Corporate Communications Farnaz Khadem, 760-603-7245 Farnaz.khadem@invitrogen.com Source: Life Technologies Corporation
